Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroid hormone receptor gamma is a non-canonical or species-specific isoform of the thyroid hormone receptor family, which primarily consists of the alpha and beta subtypes in humans. While thyroid hormone receptors (TRs) are well-characterized nuclear receptors that act as ligand-dependent transcription factors to regulate growth, development, and metabolic homeostasis, the 'gamma' designation is not a standard human therapeutic target. In humans, the THRA and THRB genes encode the functional TR-alpha and TR-beta receptors, respectively. The term 'Thyroid hormone receptor gamma' may occasionally appear in older literature or in studies of non-mammalian species such as Xenopus laevis, but it does not correspond to a recognized human protein or a target for current drug development. Most therapeutic efforts in this space focus on TR-beta selectivity for treating metabolic conditions like non-alcoholic steatohepatitis (NASH).
Ligand-dependent transcriptional activation or repression via binding to thyroid hormone response elements (TREs) in DNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroid hormone receptor gamma (TR-gamma).